1p/19q deletions in glial tumors with oligodendroglial component: diagnostic or prognostic factor?

被引：0
|
作者：
Cinar-Kuskucu, Aysegul [1 ]
Demir, Zeynel [1 ]
Tuysuz, Emre Can [2 ]
Dogan-Ekici, Isin [3 ]
Ozkan, Ferda [3 ]
Bayrak, Omer Faruk [1 ]
Ture, Ugur [4 ]
机构：
[1] Yeditepe Univ, Sch Med, Med Genet, Istanbul, Turkey
[2] Yeditepe Univ, Inst Sci, Biotechnol, Istanbul, Turkey
[3] Yeditepe Univ, Sch Med, Pathol, Istanbul, Turkey
[4] Yeditepe Univ, Sch Med, Neurosurg, Istanbul, Turkey
来源：
CHROMOSOME RESEARCH | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
3.P67
引用
收藏
页码：S106 / S107
页数：2
相关论文
共 50 条
  • [31] 1p/19q chromosomal deletions in metastatic oligodendroglioma.
    Palmer, CA
    Merrell, R
    Nabors, LB
    Perry, A
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (05): : 457 - 457
  • [32] 1p/19q Co-Deletion and Polysomy in Oligodendroglial Tumors - A Single Institution Study
    Chen, H.
    Stewart, C.
    Marc, R.
    Jason, H.
    Lu, W.
    Suresh, J.
    Khedoudja, N.
    Meera, H.
    LABORATORY INVESTIGATION, 2013, 93 : 415A - 415A
  • [33] Can morphology predict 1p/19q loss in oligodendroglial tumours?
    Scheie, D.
    Cvancarova, M.
    Mork, S.
    Skullerud, K.
    Andresen, P. A.
    Benestad, I.
    Helseth, E.
    Meling, T.
    Beiske, K.
    HISTOPATHOLOGY, 2008, 53 (05) : 578 - 587
  • [34] Multiplex ligation-dependent probe amplification (MLPA) in the diagnosis of 1p/19q deletions in oligodendroglial tumours
    Grobler, M.
    Vast, M.
    Elderfield, K.
    Butler, S.
    Marks, K.
    Taylor, R.
    Bridges, L. R.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2011, 37 : 16 - 17
  • [35] 1P, 19Q, 9P AND 10Q CHROMOSOMAL DELETIONS: THE IMPLICATIONS ON TREATMENT RESPONSE IN PROGRESSED OLIGODENDROGLIAL TUMOURS
    Campbell, B.
    Horsman, D.
    Maguire, J.
    Young, S.
    Curman, D.
    Ma, R.
    Thiessen, B.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S38 - S38
  • [36] A "Weighted" Fluorescence In Situ Hybridization Strengthens the Favorable Prognostic Value of 1p/19q Codeletion in Pure and Mixed Oligodendroglial Tumors
    Senetta, Rebecca
    di Cantogno, Ludovica Verdun
    Chiusa, Luigi
    Castellano, Isabella
    Gugliotta, Patrizia
    Sapino, Anna
    Cassoni, Paola
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (05): : 432 - 441
  • [37] Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?
    Gadji, Macoura
    Fortin, David
    Tsanaclis, Ana-Maria
    Drouin, Regen
    CANCER GENETICS AND CYTOGENETICS, 2009, 194 (01) : 12 - 22
  • [38] Re: Multiplex ligation dependent probe amplification for the detection of 1P and 19Q loss in oligodendroglial tumors
    Jeuken, JWM
    Boots-Sprenger, SHE
    Wesseling, P
    BRAIN PATHOLOGY, 2005, 15 (04) : 364 - 364
  • [39] Anaplastic Oligodendroglial Tumors Harboring 1p/19q Deletion Can Be Successfully Treated without Radiotherapy
    Iwadate, Yasuo
    Matsutani, Tomoo
    Shinozaki, Natsuki
    Saeki, Naokatsu
    ANTICANCER RESEARCH, 2011, 31 (12) : 4475 - 4479
  • [40] Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors
    Srebotnik-Kirbis, Irena
    Limback-Stokin, Clara
    JOURNAL OF NEURO-ONCOLOGY, 2016, 129 (03) : 415 - 422
12345